Double-blind placebo controlled study of the adjunctive effect of tropisetron on cognitive deficits in schizophrenia

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2010
INTERVENTION: 10mg of tropisetron daily during 8 weeks placebo during 8 weeks CONDITION: schizophrenia PRIMARY OUTCOME: cognitive function of the patient at 4, and 8 weeks after starting SECONDARY OUTCOME: mental status, quality of life, and so on of the patient at 4, and 8 weeks after starting INCLUSION CRITERIA: outpatient of Chiba University Hospital with schizophrenia meeting the DSM‐IV‐TR criteria taking risperidone (2‐6 mg/day) for at least 8 weeks
Epistemonikos ID: 372d708968f0dc320e848ebeddbc60bf79d567a0
First added on: Aug 22, 2024